Study S001687

EFFECTIVENESS AND COST OF INTEGRATING A PROTOCOL WITH USE OF LIRAGLUTIDE 3.0 MG INTO AN OBESITY SERVICE: (STRIVE Study)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

Included trial: extracted data ClinicalTrials.gov record Study Protocol (PDF)Statistical Analysis Plan (PDF)

Registration

Registration: NCT03036800
Acronym: STRIVE
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: COMPLETED
Enrollment: 392
Start: 2017-11-28
Primary completion: 2021-02-28
Lead sponsor: University of Leicester
Conditions: Obesity; Weight Loss; Diabetes Mellitus
Interventions: DRUG:Saxenda; OTHER:Specialist Obesity Management Services
Results posted: TRUE
Individual participant data sharing: NO

Registered primary outcomes

Weight Loss of ≥15% From Baseline (Complete Cases) [52 weeks]
Weight Loss of ≥15% From Baseline (Intention to Treat) [52 weeks]
Weight Loss of ≥15% From Baseline (Per Protocol) [52 weeks]
Weight Loss of ≥15% From Baseline (Per Protocol Without Excluded Concomitant Medications) [52 weeks]

Linked records (2)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

Record	Title	Year	Design	Identifiers	Link basis
R0020855	Effectiveness of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in weight management services (STRIVE study): a multicentre, open-label, parallel-group, randomized controlled trial. Papamargaritis D, The Lancet regional health. Europe	2024	Randomized trial	PMID 38803628 DOI	cites ClinicalTrials.gov:NCT03036800; registry reference DERIVED:38803628
R0026732	Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial. Papamargaritis D, BMJ open	2020	Protocol	PMID 32060156 DOI	cites ClinicalTrials.gov:NCT03036800; registry reference DERIVED:32060156